Another Reason to Update Your Biocompatibility Approach: EU MDRs
SyncThink Goes for Magic Leap to Get into AR
ArcherDx Seeking Broader Reach for Cancer Diagnostic
New Study Finds Discrepancies in Cervical Cancer Screening Rates
Veracyte Finds Ally in J&J for Early Lung Cancer Detection
Consider the Most Probable Number Method for Bioburden Testing
7 Key Events That Solidified the Liquid Biopsy Market
Supplier Stories for the Week of August 5
MDxHealth’s Liquid Biopsy Test Proven to Be Cost-Effective